Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study
Thomas F. Stoop(Amsterdam University of Applied Sciences), Jin He(Johns Hopkins University), Jeanne Dembinski(Hôpital Beaujon), Damiano Caputo(Università Campus Bio-Medico), Yuta Ushida(Japanese Foundation For Cancer Research), Keith Roberts(University of Alabama at Birmingham Hospital), Motokazu Sugimoto(National Cancer Center Hospital East), Atsushi Oba(Tokyo Medical and Dental University), Bas Groot Koerkamp, Paul Suno Krohn(Copenhagen University Hospital), Zohra Aslami(Johns Hopkins University), Mahsoem Ali(Amsterdam Neuroscience), Yu Takahashi(Japanese Foundation For Cancer Research), Knut Jørgen Labori(Oslo University Hospital), Tomohisa Yamamoto(Kansai Medical University), Stefan Kobbelgaard Burgdorf(Copenhagen University Hospital), Safi Dokmak(Université Paris Cité), Daisuke Hashimoto(Kansai Medical University), Stefano Crippa(Vita-Salute San Raffaele University), Naoto Gotohda(Shizuoka Cancer Center), Elisabetta Sereni(University of Verona), Kimitaka Tanaka(Hokkaido University), Massimo Falconi(Vita-Salute San Raffaele University), Alessandro Coppola(Sapienza University of Rome), Vismaya S. Bachu(University of California, Los Angeles), Geert Kazemier(European Organisation for Research and Treatment of Cancer), N. Chatzizacharias(Medical College of Wisconsin), Giulio Belfiori(Vita-Salute San Raffaele University), Michael G. House(Indiana University – Purdue University Indianapolis), Alain Sauvanet(Hôpital Beaujon), Trang K. Nguyen(Indiana University School of Medicine), Akio Saiura(The Cancer Institute Hospital), Sohei Satoi(Kansai Medical University), Richard D. Schulick(University of Colorado Anschutz Medical Campus), Dyre Kleive(Oslo University Hospital), Ammar A. Javed(NYU Langone Health), Salvador Rodriguez Franco(University of Colorado Anschutz Medical Campus), Jacob L. van Dam(Erasmus MC Cancer Institute), Isabel M. Feld(Amsterdam University Medical Centers), William R. Burns(Johns Hopkins University), Toru Nakamura(Hokkaido University), Satoshi Hirano(Hokkaido University), Hirofumi Ishida(Juntendo University), Yosuke Inoue(Japanese Foundation For Cancer Research), Minoru Tanabe(Tokyo Institute of Technology), Yan‐Dong Wu(Hengyang Normal University), Mohammed Al-Musawi(University of Colorado Anschutz Medical Campus), Ajay N. Jain(University of Oklahoma Health Sciences Center), Braden N. Miller(University of Oklahoma Health Sciences Center), Keiichi Akahoshi(Tokyo Medical and Dental University)
Cited by 8
Related Papers
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k